EVO ICL vs PRK: Which Is Better? | Lasik Awards

Quick Answer

EVO ICL is generally preferred over PRK for patients with high myopia (above -6D), thin corneas insufficient for any laser ablation, or dry eye conditions. PRK is a strong alternative for patients with moderate myopia (up to -8D) and thin corneas that disqualify them from LASIK but retain enough tissue for a safe PRK ablation. Both procedures achieve excellent long-term visual outcomes, but EVO ICL has a faster visual recovery and superior optical quality at higher prescriptions.

Detailed Explanation

PRK (Photorefractive Keratectomy) and EVO ICL represent two fundamentally different approaches to vision correction — laser reshaping of the cornea versus lens implantation. Understanding their differences in candidacy, recovery, visual quality, and cost helps patients make an informed choice between them.

How PRK works:

PRK is the predecessor to LASIK and uses the same excimer laser to reshape the corneal stroma. The difference from LASIK is the surface access method: rather than creating a flap, PRK removes the corneal epithelium (the outermost cell layer) entirely. After the epithelium is removed, the laser ablation is applied directly to the stromal surface. The epithelium then regenerates naturally over 4 to 5 days.

PRK advantages over LASIK:

No flap means no flap-related complications
Slightly better for very thin corneas (no tissue is lost to flap creation)
Slightly better long-term structural integrity

PRK disadvantages compared to LASIK:

Significantly longer and more uncomfortable recovery (5 to 7 days of blurry vision and discomfort while the epithelium heals)
Vision stabilization takes 1 to 3 months rather than days
Higher rate of temporary corneal haze (usually resolves)

EVO ICL vs. PRK — key dimensions:

Prescription range:

PRK safely corrects myopia up to approximately -10D to -12D in select patients, though optimal outcomes are in the -1D to -8D range. EVO ICL corrects -3D to -20D. For prescriptions above -10D, EVO ICL is almost always the preferred choice due to predictably superior visual outcomes.

Corneal thickness:

Both EVO ICL and PRK benefit patients with thinner corneas. PRK still requires a safe residual stromal bed — less tissue is consumed than LASIK, but the lower limit still applies. Patients with truly thin corneas (below ~470 microns) may find that even PRK approaches the safety threshold. EVO ICL has no corneal thickness requirement.

Recovery experience:

This is one of the most significant practical differences:

For patients who cannot afford extended time off from work or who have professional or personal obligations dependent on functional vision, EVO ICL’s faster recovery is a meaningful advantage.

Visual quality:

Both procedures achieve high rates of 20/20 or better vision. At lower prescription ranges, PRK produces excellent optical quality. At higher prescriptions, EVO ICL consistently demonstrates superior contrast sensitivity and night vision outcomes due to its avoidance of corneal reshaping, which can induce higher-order aberrations.

For a directory of surgeons recognized for EVO ICL clinical excellence, visit the EVO ICL Awards page.

Cost comparison:

PRK typically costs $1,500 to $2,500 per eye — less than EVO ICL ($3,500 to $5,500 per eye) primarily because no implantable device is involved. For patients who qualify for both, this cost differential may be a deciding factor, particularly if the prescription is in the range where both procedures produce comparable outcomes.

Long-term stability:

Both procedures produce stable long-term results in most patients. EVO ICL has the additional advantage of reversibility — if something changes, the lens can be removed or replaced. PRK, like LASIK, permanently modifies the cornea. This reversibility factor carries increasing weight as patients consider the possibility of future prescription changes or cataract surgery requiring corneal modification.

Dry eye:

Both EVO ICL and PRK are generally preferred over LASIK for patients with dry eye. PRK severs fewer corneal nerves than LASIK (no flap), which reduces the dry eye worsening seen with LASIK. EVO ICL does not alter the cornea at all and has essentially no impact on dry eye. For patients with existing dry eye, EVO ICL carries the lower risk of the two.

Important Considerations

The overlap zone between EVO ICL and PRK candidacy — prescriptions from -3D to -10D in patients with moderate corneal thickness — is where the choice becomes genuinely difficult. A skilled refractive surgeon will not give you a definitive recommendation without comprehensive measurements and a discussion of your specific priorities.

Key personal factors that often tip the scale:

Recovery time available: If you cannot take a week off work, PRK’s slow recovery is a significant problem. EVO ICL is favorable.
Cost: If budget is a firm constraint and the prescription is moderate, PRK may be a medically appropriate and more affordable option.
Reversibility preference: Patients who place high value on the ability to undo the procedure lean toward EVO ICL.
Anxiety about intraocular surgery: Some patients are significantly more comfortable with surface laser treatment than with an intraocular procedure. This is a legitimate psychological factor.

What to Do Next

Bring your most recent refraction data and corneal topography to your consultation. Ask your surgeon to run the numbers for both PRK and EVO ICL candidacy, and to explain where your prescription falls relative to each procedure’s optimal treatment range.

Review Who Is Not a Good Candidate for EVO ICL? to understand EVO ICL-specific disqualification criteria.

EVO ICL vs PRK: Which Is Better? | Lasik Awards

Quick Answer

Detailed Explanation

Important Considerations

What to Do Next

Related Questions